# Comparative Metabolomics Reveals the Adaptive Strategy of White Auricularia cornea to Bamboo Substrate Variation

**Authors:** Xianqi Shan, Fangjie Yao, Lixin Lu, Xiaoxu Ma, Ming Fang, Wei Liu, Jia Lu, Shengtao Qu, Zirui Zhao, Haimeng Zhao, Xu Sun, Zufa Zhou

PMC · DOI: 10.3390/jof12020140 · Journal of Fungi · 2026-02-13

## TL;DR

This study explores how white Auricularia cornea adapts to bamboo substrates, finding that a 58% bamboo mix optimizes growth and provides insights for sustainable mushroom cultivation.

## Contribution

The study identifies optimal bamboo substrate ratios and metabolic adaptation mechanisms for white Auricularia cornea cultivation.

## Key findings

- White A. cornea grows best with 58% bamboo substrate, showing a mycelial growth rate of 3.55 mm/d and shortest growth period of 86.2 days.
- Metabolomics analysis detected 3779 metabolites, with amino acids and organic acids being the most abundant.
- KEGG pathway analysis showed that bamboo substrate ratios influence growth adaptation through nucleotide metabolism and ABC transporters.

## Abstract

To address the “fungus-forest conflict” in the edible mushroom industry and the challenge of resource utilization for bamboo substrate waste, this study focused on white Auricularia cornea, and cultivation systems were established with bamboo substrate replacing wood chips at ratios of 0%, 18%, 38%, 58%, and 78%. By integrating liquid chromatography–tandem mass spectrometry (LC-MS/MS) analysis with agronomic trait measurements, the study elucidated the metabolic adaptation mechanisms of the substrate. Results indicated that white A. cornea could grow normally in all bamboo substrates, with the 58% bamboo substrate replacement group (D_58) demonstrating the most optimal overall performance. The mycelial growth rate reached 3.55 ± 0.24 mm/d, and the growth period was the shortest (86.2 d), balancing growth efficiency with cost advantages. Metabolomics detected 3779 metabolites, primarily amino acids and their derivatives (42.2%) and organic acids (35.54%). Compared to the control group, each treatment group exhibited 104–528 upregulated and 192–630 downregulated differential metabolites, with 93 shared differential metabolites and numerous unique markers. KEGG pathway enrichment analysis revealed that varying bamboo substrate ratios shaped growth adaptation strategies by regulating core pathways such as nucleotide metabolism and ABC transporters. This study established the feasibility and optimal formulation of bamboo substrate substitution, elucidated the substrate–metabolite–phenotype linkage mechanism, and provided theoretical foundations and practical references for high-quality cultivation of white A. cornea and sustainable development through “substituting bamboo for wood” to reduce carbon emissions.

## Linked entities

- **Species:** Auricularia cornea (taxon 1238391)

## Full-text entities

- **Diseases:** injury to (MESH:D014947), C (OMIM:211750), amoebiasis (MESH:D000562), Escherichia coli infection (MESH:D004927), DMs (MESH:D012734), Chagas disease (MESH:D014355), pertussis (MESH:D014917)
- **Chemicals:** Vanylglycol (MESH:D008734), D (MESH:D003903), 14,15-DiHETE (-), 12-Methyltridecanoic acid (MESH:C069641), Oxfenicine (MESH:C023010), cutin (MESH:C000521), 2'-Deoxyguanosine 5'-monophosphate (MESH:C007257), 1,2,4-Benzenetriol (MESH:C013038), Thioperamide (MESH:C052075), N-Methylpyridinium (MESH:C014677), Guanosine-5'-monophosphate (MESH:D006157), Noroxycodone (MESH:C077256), oligopeptide (MESH:D009842), acid (MESH:D000143), formic acid (MESH:C030544), wheat bran (MESH:D004043), Oxoamide (MESH:C034960), phosphatidylinositol (MESH:D010716), glycerophospholipids (MESH:D020404), avocadyne (MESH:C000709181), Proline betaine (MESH:C003342), Farnesyl acetate (MESH:C037088), Pro-Tyr (MESH:C074016), polysaccharides (MESH:D011134), Ethyl maltol (MESH:C052408), caprolactam (MESH:D002209), N-Acetyl-L-arginine (MESH:C000015), methane (MESH:D008697), Podofilox (MESH:D011034), N (MESH:D009584), Steviol (MESH:C012042), DA (MESH:C025953), Monocrotaline (MESH:D016686), AA (MESH:D000596), Sapropterin (MESH:C003402), Salsolinol (MESH:C036617), acetonitrile (MESH:C032159), 2-ADGA (MESH:C035547), 4-Methylbenzyl alcohol (MESH:C076463), amines (MESH:D000588), ketones (MESH:D007659), Crotonic acid (MESH:C569473), wax (MESH:D014885), 4-Hydroxystyrene (MESH:C030626), tricarboxylic acid (MESH:D014233), C (MESH:D002244), pentose phosphate (MESH:D010428), Heneicosanoic acid (MESH:C517970), leucine (MESH:D007930), lignin (MESH:D008031), benzene (MESH:D001554), water (MESH:D014867), Adenosine-5'-triphosphate (MESH:D000255), betaine aldehyde (MESH:C026820), alpha-Linolenic acid (MESH:D017962), valine (MESH:D014633), 4-Heptanone (MESH:C038029), Lys-Val (MESH:C110469), Octadecylamine (MESH:C009317), vancomycin (MESH:D014640)
- **Species:** Hericium erinaceus (bearded tooth mushroom, species) [taxon 91752], Auricularia heimuer (species) [taxon 1579977], Lentinula edodes (shiitake mushroom, species) [taxon 5353], Agaricus bisporus (common mushroom, species) [taxon 5341], Manihot esculenta (cassava, species) [taxon 3983], Bambuseae (bamboo, tribe) [taxon 147376], Eucalyptus (genus) [taxon 3932], Auricularia cornea (species) [taxon 1238391], Saccharomyces cerevisiae (baker's yeast, species) [taxon 4932], Homo sapiens (human, species) [taxon 9606], Pleurotus ostreatus (oyster mushroom, species) [taxon 5322]
- **Cell lines:** 38 — Mus musculus (Mouse), Hybridoma (CVCL_J877), C — Mus musculus (Mouse), Finite cell line (CVCL_S361), A_CK — Bos taurus (Bovine), Spontaneously immortalized cell line (CVCL_W462)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12941403/full.md

## Figures

7 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12941403/full.md

## References

58 references — full list in the complete paper: https://tomesphere.com/paper/PMC12941403/full.md

---
Source: https://tomesphere.com/paper/PMC12941403